Co-Diagnostics Price to Free Cash Flow Ratio 2017-2025 | CODX
Historical price to free cash flow ratio values for Co-Diagnostics (CODX) since 2017.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Co-Diagnostics Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-06-18 | 0.28 | 0.00 | |
| 2025-03-31 | 0.31 | $-0.96 | 0.00 |
| 2024-12-31 | 0.75 | $-0.99 | 0.00 |
| 2024-09-30 | 1.25 | $-0.89 | 0.00 |
| 2024-06-30 | 1.25 | $-0.85 | 0.00 |
| 2024-03-31 | 1.12 | $-0.89 | 0.00 |
| 2023-12-31 | 1.33 | $-0.80 | 0.00 |
| 2023-09-30 | 1.06 | $-0.76 | 0.00 |
| 2023-06-30 | 1.11 | $-0.52 | 0.00 |
| 2023-03-31 | 1.48 | $-0.26 | 0.00 |
| 2022-12-31 | 2.52 | $0.16 | 15.43 |
| 2022-09-30 | 3.21 | $0.46 | 6.94 |
| 2022-06-30 | 5.61 | $0.80 | 7.04 |
| 2022-03-31 | 6.18 | $1.16 | 5.32 |
| 2021-12-31 | 8.93 | $1.35 | 6.61 |
| 2021-09-30 | 9.73 | $1.90 | 5.12 |
| 2021-06-30 | 8.25 | $1.81 | 4.55 |
| 2021-03-31 | 9.54 | $1.45 | 6.60 |
| 2020-12-31 | 9.30 | $0.98 | 9.51 |
| 2020-09-30 | 13.59 | $0.16 | 84.57 |
| 2020-06-30 | 19.35 | $-0.19 | 0.00 |
| 2020-03-31 | 7.62 | $-0.31 | 0.00 |
| 2019-12-31 | 0.90 | $-0.34 | 0.00 |
| 2019-09-30 | 1.03 | $-0.31 | 0.00 |
| 2019-06-30 | 0.80 | $-0.33 | 0.00 |
| 2019-03-31 | 1.06 | $-0.34 | 0.00 |
| 2018-12-31 | 1.49 | $-0.33 | 0.00 |
| 2018-09-30 | 2.63 | $-0.36 | 0.00 |
| 2018-06-30 | 3.88 | $-0.46 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.009B | $0.004B |
| Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.092B | 26.27 |
| CVS Health (CVS) | United States | $84.870B | 10.55 |
| Elevance Health (ELV) | United States | $84.768B | 10.94 |
| Cencora (COR) | United States | $56.829B | 19.77 |
| Natera (NTRA) | United States | $22.878B | 0.00 |
| DiDi Global (DIDIY) | China | $22.356B | 23.75 |
| Labcorp Holdings (LH) | United States | $21.716B | 17.61 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.887B | 0.00 |
| Solventum (SOLV) | United States | $12.588B | 13.33 |
| CochLear (CHEOY) | Australia | $12.104B | 0.00 |
| ICON (ICLR) | Ireland | $11.456B | 10.65 |
| Revvity (RVTY) | United States | $11.099B | 19.10 |
| Doximity (DOCS) | United States | $10.990B | 50.88 |
| Viatris (VTRS) | United States | $10.281B | 3.53 |
| Avantor (AVTR) | United States | $8.961B | 13.02 |
| HealthEquity (HQY) | United States | $8.648B | 37.88 |
| Medpace Holdings (MEDP) | United States | $8.563B | 22.74 |
| Sonic Healthcare (SKHHY) | Australia | $8.268B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.124B | 13.96 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.096B | 24.12 |
| BrightSpring Health Services (BTSG) | United States | $3.753B | 34.44 |
| Sotera Health (SHC) | United States | $3.108B | 17.66 |
| Alignment Healthcare (ALHC) | United States | $2.883B | 0.00 |
| Concentras Parent (CON) | United States | $2.704B | 15.63 |
| Surgery Partners (SGRY) | United States | $2.605B | 33.88 |
| Organon (OGN) | United States | $2.561B | 2.72 |
| PACS (PACS) | United States | $1.882B | 0.00 |
| Progyny (PGNY) | United States | $1.846B | 40.62 |
| Premier (PINC) | United States | $1.832B | 13.91 |
| GeneDx Holdings (WGS) | United States | $1.827B | 70.37 |
| Ardent Health (ARDT) | United States | $1.818B | 7.75 |
| GoodRx Holdings (GDRX) | United States | $1.568B | 31.36 |
| Teladoc Health (TDOC) | United States | $1.242B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.152B | 8.76 |
| CareDx (CDNA) | United States | $1.087B | 16.97 |
| Establishment Labs Holdings (ESTA) | $1.082B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.869B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.842B | 7.88 |
| QDM (QDMI) | Hong Kong, SAR China | $0.758B | 0.00 |
| Nutex Health (NUTX) | United States | $0.642B | 9.71 |
| LifeMD (LFMD) | United States | $0.617B | 0.00 |
| Embecta (EMBC) | United States | $0.575B | 3.87 |
| InnovAge Holding (INNV) | United States | $0.505B | 0.00 |
| Enhabit (EHAB) | United States | $0.485B | 39.92 |
| Auna S.A (AUNA) | Luxembourg | $0.472B | 10.63 |
| SBC Medicals (SBC) | United States | $0.469B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.454B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.419B | 0.00 |
| Omada Health (OMDA) | $0.390B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.261B | 0.00 |
| Oncology Institute (TOI) | United States | $0.209B | 0.00 |
| Beauty Health (SKIN) | United States | $0.193B | 0.00 |
| DocGo (DCGO) | United States | $0.163B | 26.67 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.115B | 0.00 |
| So-Young (SY) | China | $0.104B | 0.00 |
| OncoCyte (OCX) | United States | $0.092B | 0.00 |
| KindlyMD (NAKA) | United States | $0.089B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.050B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Biodesix (BDSX) | United States | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |